Log in to save to my catalogue

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3bc5e182a9d74ba1be1ee7505b0b6394

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma

About this item

Full title

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Case reports in oncological medicine, 2018-01, Vol.2018 (2018), p.1-7

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Introduction. Chordomas are rare malignancies of bone origin that occur in the axial skeleton, typically the skull base and lumbar/sacral regions. Although often classified as low-grade neoplasms, its locally infiltrative behavior may result in significant morbidity and mortality. Optimal surgical resection may be curative, but up to 50% of the cas...

Alternative Titles

Full title

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3bc5e182a9d74ba1be1ee7505b0b6394

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3bc5e182a9d74ba1be1ee7505b0b6394

Other Identifiers

ISSN

2090-6706

E-ISSN

2090-6714

DOI

10.1155/2018/4290131

How to access this item